Does SORAFENIB Cause Hepatocellular carcinoma? 1,665 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,665 reports of Hepatocellular carcinoma have been filed in association with SORAFENIB (sorafenib). This represents 15.3% of all adverse event reports for SORAFENIB.
1,665
Reports of Hepatocellular carcinoma with SORAFENIB
15.3%
of all SORAFENIB reports
492
Deaths
306
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From SORAFENIB?
Of the 1,665 reports, 492 (29.5%) resulted in death, 306 (18.4%) required hospitalization, and 40 (2.4%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
Yes, Hepatocellular carcinoma is listed as a known adverse reaction in the official FDA drug label for SORAFENIB.
What Other Side Effects Does SORAFENIB Cause?
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
Weight decreased (598)
What Other Drugs Cause Hepatocellular carcinoma?
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which SORAFENIB Alternatives Have Lower Hepatocellular carcinoma Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK